司马替利
|
|
- CAS号:
- 101526-83-4
- 英文名:
- N-(DIETHYLAMINOETHYL)-4-METHYLSULFOAMINOBENZAMIDE
- 英文别名:
- RU-752;Sematilide;N-(diethyl-amino-ethyl-)-4-mesyl-amino-benz-amide;N-(DIETHYLAMINOETHYL)-4-METHYLSULFOAMINOBENZAMIDE;N-(2-Diethylaminoethyl)-4-(methylsulfonylamino)benzamide;N-(2-(DiethylaMino)ethyl)-4-(MethylsulfonaMido)benzaMide;N-[2-(DIETHYLAMINO)ETHYL]-4-(METHANESULFONAMIDO)BENZAMIDE;Benzamide,N-[2-(diethylamino)ethyl]-4-[(methylsulfonyl)amino]-
- 中文名:
- 司马替利
- 中文别名:
- 司马替利;司美利特;化合物 T12879
- CBNumber:
- CB3246821
- 分子式:
- C14H23N3O3S
- 分子量:
- 313.42
- MOL File:
- 101526-83-4.mol
|
|
|
司马替利化学性质
-
密度:
-
1.205±0.06 g/cm3(Predicted)
-
|
-
酸度系数(pKa):
-
7.43±0.10(Predicted)
-
|
司马替利性质、用途与生产工艺
Sematilide (CK-1752) 是一种选择性的 IKr 通道阻滞剂。Sematilide 抑制延迟整流钾通道 (K+ current),IC50 为 25 μM,这种作用存在浓度依赖性。Sematilide 是一种 III 类抗心律不齐剂。
IC50: 25 μM (K
+
current)
Application of 10, 30, 100 and 300 μM Sematilide causes a concentration-dependent inhibition of the delayed rectifier K
+
current (IC
50
=25 μM).
Sematilide (0.3-1.0 mg/kg, intravenously i.v.) is effective in a canine model of arrhythmia.
Animal Model:
|
Mongrel dogs of either sex (10-18 kg body weight)
|
Dosage:
|
0.3, 1, 3, and 10 mg/kg
|
Administration:
|
I.v. infusions
|
Result:
|
Demonstrated antiarrhythmic effects at 0.3 and 3.0 mg/kg.
|
司马替利
上下游产品信息
上游原料
下游产品
101526-83-4, 司马替利 相关搜索:
- C14H23N3O3S
- 化合物 T12879
- 司马替利
- 司美利特
- 101526-83-4
- N-(diethyl-amino-ethyl-)-4-mesyl-amino-benz-amide
- Benzamide,N-[2-(diethylamino)ethyl]-4-[(methylsulfonyl)amino]-
- N-[2-(DIETHYLAMINO)ETHYL]-4-(METHANESULFONAMIDO)BENZAMIDE
- N-(2-(DiethylaMino)ethyl)-4-(MethylsulfonaMido)benzaMide
- RU-752
- N-(2-Diethylaminoethyl)-4-(methylsulfonylamino)benzamide
- Sematilide
- N-(DIETHYLAMINOETHYL)-4-METHYLSULFOAMINOBENZAMIDE